0

    540204

    EIKO

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    EIKO LIFESCIENCES LIMITED Share Price Today

    Investment Returns

    Over 1 Month -0.86% Over 3 Months -1.79% Over 6 Months -3.33% Over 1 Year -10.44%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    EIKO LIFESCIENCES LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 70.20
    • P/E Ratio (TTM) 19.72
    • Beta 0.37
    • Book Value / share 47.04
    • Return on equity 2.75%
    • EPS (TTM) 2.50
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 1.12
    info icon alternate text

    EIKO LIFESCIENCES LIMITED Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 15.90
    Operating Expense 14.87
    Net Profit 1.12
    Net Profit Margin (%) 7.04
    Earnings Per Share (EPS) 0.80
    EBITDA 1.68
    Effective Tax Rate (%) 24.83
    Particulars DEC 2025 (Values in Cr)
    Revenue 9.57
    Operating Expense 8.88
    Net Profit 0.95
    Net Profit Margin (%) 9.92
    Earnings Per Share (EPS) 0.69
    EBITDA 1.43
    Effective Tax Rate (%) 24.19
    Particulars SEP 2025 (Values in Cr)
    Revenue 9.20
    Operating Expense 8.69
    Net Profit 0.82
    Net Profit Margin (%) 8.91
    Earnings Per Share (EPS) 0.60
    EBITDA 1.29
    Effective Tax Rate (%) 23.36
    Particulars JUN 2025 (Values in Cr)
    Revenue 7.45
    Operating Expense 7.10
    Net Profit 0.69
    Net Profit Margin (%) 9.26
    Earnings Per Share (EPS) 0.50
    EBITDA 1.08
    Effective Tax Rate (%) 24.17
    Particulars MAR 2025 (Values in Cr)
    Revenue 7.09
    Operating Expense 6.77
    Net Profit 0.90
    Net Profit Margin (%) 12.69
    Earnings Per Share (EPS) 0.69
    EBITDA 1.39
    Effective Tax Rate (%) 24.16
    Particulars MAR 2026 (Values in Cr)
    Revenue 42.13
    Operating Expense 39.54
    Net Profit 3.58
    Net Profit Margin (%) 8.49
    Earnings Per Share (EPS) 2.60
    EBITDA 5.46
    Effective Tax Rate (%) 23.99
    Particulars MAR 2025 (Values in Cr)
    Revenue 32.49
    Operating Expense 31.54
    Net Profit 1.74
    Net Profit Margin (%) 5.35
    Earnings Per Share (EPS) 1.34
    EBITDA 3.07
    Effective Tax Rate (%) 25.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 27.93
    Operating Expense 27.12
    Net Profit 0.75
    Net Profit Margin (%) 2.68
    Earnings Per Share (EPS) 0.73
    EBITDA 1.78
    Effective Tax Rate (%) 23.46
    Particulars MAR 2023 (Values in Cr)
    Revenue 18.32
    Operating Expense 18.15
    Net Profit 0.77
    Net Profit Margin (%) 4.20
    Earnings Per Share (EPS) 0.92
    EBITDA 1.81
    Effective Tax Rate (%) 25.24
    Particulars MAR 2022 (Values in Cr)
    Revenue 25.43
    Operating Expense 25.14
    Net Profit 0.71
    Net Profit Margin (%) 2.79
    Earnings Per Share (EPS) 0.90
    EBITDA 1.96
    Effective Tax Rate (%) 25.53
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 41.26
    ROE % 3.61
    ROCE % 4.84
    Total Debt to Total Equity 0.05
    EBITDA Margin 9.60
    Particulars MAR 2020 (Values in Cr)
    Book Value / Share 7.71
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.38
    EBITDA Margin -43.27
    Particulars MAR 2019 (Values in Cr)
    Book Value / Share 12.89
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.30
    EBITDA Margin -14.99
    Particulars MAR 2018 (Values in Cr)
    Book Value / Share 14.56
    ROE % 3.60
    ROCE % 4.66
    Total Debt to Total Equity 0.31
    EBITDA Margin 17.80
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 41.00
    ROE % 2.75
    ROCE % 3.84
    Total Debt to Total Equity 0.02
    EBITDA Margin 8.37
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 39.37
    ROE % 1.87
    ROCE % 2.82
    Total Debt to Total Equity 0.00
    EBITDA Margin 6.44
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 35.38
    ROE % 2.65
    ROCE % 3.79
    Total Debt to Total Equity 0.08
    EBITDA Margin 9.93
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 34.43
    ROE % 3.45
    ROCE % 6.01
    Total Debt to Total Equity 0.16
    EBITDA Margin 7.79
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 16.19
    ROE % 6.77
    ROCE % 9.15
    Total Debt to Total Equity 0.12
    EBITDA Margin 8.17
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 11.78
    Total Assets 66.10
    Total Liabilities 66.10
    Total Equity 57.00
    Share Outstanding 1
    Price to Book Ratio 1.28
    Return on Assets (%) 3.50
    Return on Capital (%) 3.88
    Particulars MAR 2020 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 12.05
    Total Liabilities 12.05
    Total Equity 1.11
    Share Outstanding 0
    Price to Book Ratio 0.71
    Return on Assets (%) -15.81
    Return on Capital (%) -70.01
    Particulars MAR 2019 (Values in Cr)
    Cash & Short Term Investments 0.11
    Total Assets 9.30
    Total Liabilities 9.30
    Total Equity 4.80
    Share Outstanding 0
    Price to Book Ratio 4.01
    Return on Assets (%) -4.77
    Return on Capital (%) -7.2
    Particulars MAR 2018 (Values in Cr)
    Cash & Short Term Investments 0.80
    Total Assets 10.95
    Total Liabilities 10.95
    Total Equity 5.78
    Share Outstanding 0
    Price to Book Ratio 3.37
    Return on Assets (%) 1.79
    Return on Capital (%) 2.63
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 11.51
    Total Assets 60.37
    Total Liabilities 60.37
    Total Equity 56.42
    Share Outstanding 1
    Price to Book Ratio 1.28
    Return on Assets (%) 2.88
    Return on Capital (%) 2.99
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 13.34
    Total Assets 52.73
    Total Liabilities 52.73
    Total Equity 50.67
    Share Outstanding 1
    Price to Book Ratio 1.31
    Return on Assets (%) 1.42
    Return on Capital (%) 1.48
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.61
    Total Assets 31.04
    Total Liabilities 31.04
    Total Equity 29.42
    Share Outstanding 0
    Price to Book Ratio 2.16
    Return on Assets (%) 2.47
    Return on Capital (%) 2.61
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.21
    Total Assets 34.89
    Total Liabilities 34.89
    Total Equity 28.62
    Share Outstanding 0
    Price to Book Ratio 1.41
    Return on Assets (%) 2.02
    Return on Capital (%) 2.13
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 4.07
    Total Assets 16.61
    Total Liabilities 16.61
    Total Equity 12.52
    Share Outstanding 0
    Price to Book Ratio 4.89
    Return on Assets (%) 3.69
    Return on Capital (%) 4.3
    Particulars MAR 2025 (Values in Cr)
    Net Income 3.06
    Cash from Operations 3.23
    Cash from Investing -11.44
    Cash from Financing 6.95
    Net change in Cash -1.56
    Free Cash Flow 13.52
    Particulars MAR 2020 (Values in Cr)
    Net Income -4.93
    Cash from Operations -0.30
    Cash from Investing -0.70
    Cash from Financing 0.94
    Net change in Cash -0.08
    Free Cash Flow -0.07
    Particulars MAR 2019 (Values in Cr)
    Net Income -0.99
    Cash from Operations 0.18
    Cash from Investing -0.29
    Cash from Financing -0.55
    Net change in Cash -0.68
    Free Cash Flow 0.38
    Particulars MAR 2025 (Values in Cr)
    Net Income 2.31
    Cash from Operations 2.33
    Cash from Investing -9.85
    Cash from Financing 5.97
    Net change in Cash -1.83
    Free Cash Flow 3.66
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.98
    Cash from Operations -7.04
    Cash from Investing -0.54
    Cash from Financing 20.36
    Net change in Cash 12.73
    Free Cash Flow -6.69
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.02
    Cash from Operations 4.14
    Cash from Investing 0.87
    Cash from Financing -4.70
    Net change in Cash 0.39
    Free Cash Flow 4.37
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.94
    Cash from Operations -7.51
    Cash from Investing 0.59
    Cash from Financing 3.28
    Net change in Cash -3.85
    Free Cash Flow -7.36
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.83
    Cash from Operations -0.64
    Cash from Investing -2.93
    Cash from Financing 7.81
    Net change in Cash 4.05
    Free Cash Flow -0.64
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ATUL LTD 6802.75 25.18 3.21 20028.49 5563.00 7198.20
    BASF INDIA LTD. 3735.80 39.14 4.08 16170.65 2906.90 5199.00
    ORIENTAL AROMATICS LTD 396.10 404.18 2.00 1333.02 227.05 399.90
    DEEPAK FERTILISERS & PETROCHEM 1625.55 27.83 2.99 20520.59 865.45 1677.85
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ADVANCE PETROCHEMICALS LTD. 172.90 0.00 3.91 15.56 97.60 320.75
    ATUL LTD 6802.75 28.68 3.30 20028.49 5563.00 7198.20
    BASF INDIA LTD. 3735.80 39.44 4.06 16170.65 2906.90 5199.00
    ORIENTAL AROMATICS LTD 396.10 52.74 1.89 1333.02 227.05 399.90

    EIKO LIFESCIENCES LIMITED shareholding pattern

    Holding
    60.09%
    39.9%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    EIKO LIFESCIENCES LIMITED Technicals Summary

    48.90 -0.83 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 49.40
    • 26 Days 49.80
    • 10 Days 49.40
    • 50 Days 50.20
    • 12 Days 49.50
    • 100 Days 50.70
    • 20 Days 49.60
    • 200 Days 51.60
    49.52 PIVOT
    First Support 48.54 First Resistance 50.28 Second Support 47.78 Second Resistance 51.26 Third Support 46.80 Third Resistance 52.02
    RSI 46.94 ADX 44.18 MACD -0.30 Williams % R -54.48 Commodity Channel Index (CCI) -14.80
    Date 2026-07-29 Week 2630.00 Same Day 3283.00 Month 6129.00
    1 Year 0.37 3 Year 0.36
    Over 1 Month
    -0.86% down
    Over 1 Year
    -10.44% down
    Over 3 Months
    -1.79% down
    Over 3 Years
    -7.30% down
    Over 6 Months
    -3.33% down
    Over 5 Years
    -10.54% down

    EIKO LIFESCIENCES LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    20 Sep 2017 0.25 Final 22 Sep 2017 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Eiko Lifesciences Ltd?

    Answer Field

    Eiko Lifesciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 48.90 as on Jul 30 2026 03:27 PM.

    What is the Market Cap of Eiko Lifesciences Ltd Share?

    Answer Field

    The market cap of Eiko Lifesciences Ltd for NSE ₹ 0.00 & for BSE ₹ 70.20 as on Jul 30 2026 03:27 PM.

    What is the 52 Week High and Low of Eiko Lifesciences Ltd?

    Answer Field

    The 52 Week High and Low of Eiko Lifesciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 64.44 and ₹ 45.90.

    What is 1 year return for Eiko Lifesciences Ltd?

    Answer Field

    The 1 year returns on the stock has been -10.44%.

    What is the P/E Ratio of Eiko Lifesciences Ltd Share?

    Answer Field

    As on Jul 30 2026 03:27 PM the price-to-earnings (PE) ratio for Eiko Lifesciences Ltd share is 19.72.

    What is the PB ratio of Eiko Lifesciences Ltd Share?

    Answer Field

    As on Jul 30 2026 03:27 PM, the price-to-book (PB) ratio for Eiko Lifesciences Ltd share is 47.04.

    How to Buy Eiko Lifesciences Ltd Share?

    Answer Field

    You can trade in Eiko Lifesciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Eiko Lifesciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Eiko Lifesciences Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Eiko Lifesciences Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |